The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients. Radiol Oncol. 2016;50(3). Accessed October 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/2546